Navigation Links
BOXX Personal Supercomputer for Research Scientists Featured at SC08
Date:11/18/2008

BOXX Technologies is leveraging its extensive experience in multi-GPU high-performance computing systems designed for cutting edge media creation to provide scientists, engineers and researchers with a GPU-based personal supercomputing capability. The BOXX Personal Supercomputer (PSC), which will be shown at the NVIDIA® booth (#833) during this week's SC08 Conference, the top international conference for high performance computing (HPC), enables scientists and engineers to analyze immense datasets, apply complex algorithms and test alternative theories--all on their desktop.

Austin, Texas (PRWEB) November 18, 2008 -- BOXX Technologies is leveraging its extensive experience in multi-GPU high-performance computing systems designed for cutting edge media creation to provide scientists, engineers and researchers with a GPU-based personal supercomputing capability. The BOXX Personal Supercomputer (PSC), which will be shown at the NVIDIA® booth (#833) during this week's SC08 Conference, the top international conference for high performance computing (HPC), enables scientists and engineers to analyze immense datasets, apply complex algorithms and test alternative theories--all on their desktop.

A product of BOXX's Innovative Integration process, the new BOXX Personal Supercomputer (PSC) is designed to accelerate the execution of highly parallelized computing tasks in biomedical research, oil & gas exploration, financial derivatives analysis and complex engineering. Researchers interested in accelerating time-to-discovery will find that the BOXX PSC delivers compact and quiet deskside GPU-based computing power.

"Boxx has built a personal supercomputer that delivers cluster class performance in a sleek chassis, making it a powerful and flexible solution for researchers wanting to unchain themselves from the datacenter," said Andrew Walsh, general manager, personal supe
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Connecticut State Medical Society and Genomas Co-Sponsor Forum on DNA-Guided Medicine and the Path to Personalized Health Care
2. As personalized, genomic medicine takes off, four developing countries show the way for others
3. OSU to Host National Personalized Health Care Conference
4. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
5. CSC and HealthTrio Team to Offer Portal and Personal Health Record Solution
6. MammaPrint(R) Breast Cancer Test Provides Valuable Insight for Personalized Treatment Decisions
7. Former CMS Administrator: "Blunt Instrument Policies an Increasingly Bad Fit in Era of Personalized Health Care"
8. CryoPort Creates Personal Wall on Wallst.nets Financial Social Community, my.wallst.net
9. U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform
10. Seduce with Mousse - Replens Introduces Intimate Options: First Personal Lubricant Mousse in Canada
11. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... -- AACC welcomed thousands of medical professionals and ... & Clinical Lab Expo in Atlanta ... revolutionary advancements in clinical testing technology and research ... diagnose patients quickly and accurately and make sure ... As of Wednesday, July 29, more than 17,500 ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... a field clinical study of its canine osteoarthritis stem cell product, currently under ... (Kansas City, KS) and will be marketed in the US by Aratana. This ...
(Date:7/30/2015)... 30, 2015 HIGHLIGHTS:Q2 2015 Results ... , Reported sales were $697 million compared to ... grew organically by 8%, and changes in foreign currency ... sales by 1%. , By business unit, organic ... and 11% in SAFC Commercial. , Reported diluted ...
(Date:7/29/2015)... , July 30, 2015 ... la santé, publie ses résultats pour le premier ... commente les résultats. Visionner l,interview ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Au sommaire de ... - Moteurs de croissance - ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20
... York, August 15 XTL,Biopharmaceuticals Ltd. (NASDAQ: ... engaged in the acquisition, development and,commercialization of therapeutics ... pain and hepatitis C, today announced its,financial results ... At June 30, 2007, the Company had ...
... Chilcott,Limited (Nasdaq: WCRX ) announced today that it ... Inc. ("Barr") advising the,Company of the filing of an ... FEMCON FE. FEMCON FE, which was introduced by ... chewable oral contraceptive and is protected by U.S. Patent,No. ...
... Aug. 15 Thoratec,Corporation (Nasdaq: THOR ), a ... that its PMA (PreMarket Application),seeking approval of its HeartMate ... panel later this year. The company said that ... date for the review by a Circulatory Systems Device ...
Cached Biology Technology:XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 2XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 3XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 4XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 5XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 6XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 7XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 8XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 9XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 10XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 11XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 12XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 13XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 14Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 2Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 3Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel 2
(Date:7/31/2015)... 2015 BGI llevará a cabo la 10ª Conferencia ... 25 de octubre de 2015, en Shenzhen, ... décimo aniversario este año. Desde su inauguración en 2006, ... anuales más influyentes del mundo en los campos de ... más dinámicas, entusiastas y amenas. ICG-10 se ...
(Date:7/31/2015)... , 31 de julio de 2015 La 10 ... se celebrará por medio de BGI del 22 al 25 de ... Este año, la conferencia celebra su décimo ... ha convertido en una de las reuniones anuales más influyentes ... de las reuniones más dinámicas, entusiastas y mejores a nivel ...
(Date:7/31/2015)... SHENZHEN, China , July 31, 2015 The ... ) will be held by BGI from October 22-25, 2015, in ... The conference is celebrating its 10 th ... become one of the world,s most influential annual meetings in ... enthusiastic, and enjoyable scientific gatherings. ICG-10 focuses ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3The 10th International Conference on Genomics (ICG-10) to Open in October 2
... (June 17, 2008) For those patients who receive ... treat their B12 deficiency, a new oral option may ... of Health, vitamin B12 deficiency can lead to a ... reduced cognitive functioning. Vitamin B12 deficiency is a significant ...
... . Montreal, 13 June 2008 ... University and the University of British Columbia (UBC) determined ... increase in serious adverse events, but are associated with ... Several drugs containing compounds derived from the cannabis plant, ...
... Assistant Investigator, has been named a Pew Scholar in ... carries an award of $240,000 over four years. ... selected on the basis of performance during education and ... science relevant to human health. The Pew Charitable Trusts ...
Cached Biology News:New technology may prevent vitamin B12 deficient seniors and vegetarians from needing injections 2Medicines derived from cannabis: a review of adverse events 2Julia Zeitlinger named Pew Scholar 2
... and negatively supercoiled DNA in presence of EDTA ... effects of supercoiling on transcription in vitro ... Determining the degree of supercoiling of naturally occurring ... in length by only one base-pair , ...
Required to perform reference file generation, flatfield calibration and performance verification processes on the GSD-501...
Applications: Immunohistochemistry, ISH, FISH, CISH....
Applications: Immunohistochemistry, ISH, FISH, CISH....
Biology Products: